Incidence, Diagnosis, and Treatment of Cardiac Toxicity from Trastuzumab in Patients with Breast Cancer

PURPOSE OF REVIEW: Treatment with trastuzumab is a cornerstone of human epidermal growth factor receptor 2 (HER2)-overexpressing breast cancer treatment, but carries an unfortunate risk of toxicity to the cardiovascular system. Here we review recent findings on trastuzumab-associated cardiotoxicity,...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Curr Breast Cancer Rep
Egile Nagusiak: Nowsheen, Somaira, Viscuse, Paul V, O’Sullivan, Ciara C., Sandhu, Nicole P., Haddad, Tufia C., Blaes, Anne, Klemp, Jennifer, Nhola, Lara, Herrmann, Joerg, Ruddy, Kathryn J.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: 2017
Gaiak:
Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC5718359/
https://ncbi.nlm.nih.gov/pubmed/29225726
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s12609-017-0249-4
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak